FDA Import Refusal AEK-2075272-0/100002/1 — Glen Mark Pharmaceuticals

Glen Mark Pharmaceuticals — FEI 3004574695

The FDA refused shipment AEK-2075272-0/100002/1 from Glen Mark Pharmaceuticals (India) on Sep 20, 2026. The refused product falls under Drugs and Biologics — KETOCONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Sep 20, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61WDJ47 KETOCONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.